Background: to prevent diabetic foot disease, proper foot care is essential for early detection and treatment. Pharmacists are well suited to provide accessible foot care to adults with type 2 diabetes. Limited research has examined this role.
Background
Diabetic foot disease is a devastating complication of diabetes. The lifetime incidence of foot disease for people with diabetes has been consistently reported between 15% and 25%, 1 with some estimates as high as 34%. 2 For the individual, living with foot ulceration, infection and/or amputation can reduce quality of life 3, 4 and increase risk of death. 5 For the community and society, foot infections are the leading cause of hospitalization for people living with diabetes 6 and costly for all.
The management of diabetes-related foot complications contributes significantly to the high costs of diabetes care. 7 Though amputation is the most severe foot-related complication with highest health care costs, foot ulceration can be considered the precursor. 8 Here lies the potential for early intervention and management, SYSTeMATiC ReView preventing further invasive foot disease. Hopkins et al. 6 estimated the economic burden associated with diabetic foot ulceration at CAN$540 million, and it is increasing over time. They call on improvements to the management, prevention and early treatment of foot ulcers to slow or halt the human and economic burden. 6 Current best practice and clinical practice guidelines state that people with diabetes should examine their own feet daily, with clinical evaluation by a health care provider at least every 12 months. 9 The literature has reported low rates of foot examinations, 10 References from identified systematic reviews were also searched for additional studies. Searches were restricted to the English language. No study design limits or age restrictions were applied. Key words and synonyms included the following: diabet*, foot*, pharm*, drugstore, druggist, apothecar*, dispensary, clinical monitoring, self-care, screening, wound management, pharmacist, podiatr*, chiropod*. The inclusion criteria were full-text, original studies, published in English, with a community pharmacy-based or pharmacist-led intervention with a foot care component targeting adults with type 2 diabetes. Multicomponent programs with a foot-specific outcome were included, as well as those with either a self-care or health care provider (i.e., pharmacist) foot care focus. Those requiring a referral or located in a hospital/clinic/medical office were excluded. In addition, team-based care and programs where it was unclear which health care provider performed the foot care intervention were excluded.
The study selection process is illustrated in Figure 1 . Studies were abstracted into EndNote, version X7.8, where duplicate studies were removed. The studies were initially screened for title and abstract by one reviewer. Full-text studies were assessed for eligibility by 2 reviewers. Any discrepancies were discussed with a third reviewer until consensus was reached.
KNOWLEDGE INtO PrActIcE
• Pharmacists are capable of providing a variety of foot care interventions to patients with diabetes in the community setting. Limited research has documented the role pharmacists play in foot care practices.
• this study reports evidence from many sources, summarizing current community pharmacy-based and pharmacist-led foot care interventions.
• this study may influence future pharmacy practice for patients with diabetes, emphasizing the inclusion of foot care interventions into diabetes care planning in the community pharmacy setting.
MIsE EN PrAtIQUE DEs cONNAIssANcEs
• En milieu communautaire, les pharmaciens sont en mesure d'effectuer un éventail d'interventions en matière de soins des pieds chez les patients atteints de diabète. très peu de recherches ont documenté le rôle du pharmacien à cet égard.
• cette étude présente des données probantes issues de sources diverses et résume les interventions en matière de soins des pieds menées par des pharmaciens dans les pharmacies communautaires.
• L'étude pourrait influencer la pratique future des pharmaciens en milieu communautaire en insistant sur l'inclusion d'interventions en matière de soins de pieds dans la planification des soins offerts aux patients atteints de diabète.
SYSTeMATiC ReView
The following data elements were extracted: general characteristics (author names, year published, country of implementation, study design, sample size, description of the intervention and outcome measured [foot care specific]) and study findings summarized (gender, age, duration of diabetes, baseline A1C). Quality of the included studies was assessed with the Downs and Black 13 27-item checklist. This checklist allows the methodological quality assessment of both randomized and nonrandomized studies in 5 dimensions: reporting, confounding, bias, external validity and power. Two independent reviewers conducted the quality assessment separately, discussed discrepancies and came to consensus on scores. In the case of disagreement, a third reviewer was consulted. Studies were classified as either self-care or health care provider exam-focused interventions.
Results
Our database searches identified 817 articles (including Google Scholar). As well, 200 Google results and 16 hand-searched articles were examined. We removed 244 duplicates from the database searches and 9 Google duplicates, moving 780 results forward for initial screening; 402 database and 184 Google articles were removed based on title and abstract. Main exclusions in the initial screening were for animal studies, hospital/acute care settings and specific pharmacotherapy and surgical interventions. Two independent reviewers initially assessed 194 (171 database, 7 Google, 16 additional) articles; 187 were excluded due to the following reasons: 108 publication type (i.e., was not original research), 12 sample population (i.e., was not adults with type 2 diabetes), 54 intervention (i.e., was not pharmacy based or pharmacist led) and 13 outcome (i.e., did not have a foot care-specific outcome). Overall, 7 studies were included in this systematic review.
General characteristics of included studies
Three studies focused on improving foot selfcare behaviours, and 4 studies focused on promoting foot examinations by health care providers (pharmacist or other) ( Table 1) . Six out of Quality assessment Downs and Black 13 27-item quality assessment scores are reported as percentages out of a total score of 32, with high-quality studies scoring greater than 50%, medium quality between 40% and 50% and low quality less than 39% (Table 2) . Both randomized controlled trials scored over 50%, representing high-quality evaluation. One study scored 44%, and the remaining 4 studies scored 25% to 38%. The 3 highest scoring studies all focused on improving foot self-care behaviours, while the lower scoring studies all focused on promoting health care provider foot examinations.
Overall findings
The studies reported in this systematic review varied in purpose, design, intervention and outcome; therefore, we are unable to pool any results. The overall summary of findings is reported in Table 3 and Figure 2 . Six out of 7 studies reported an average age of over 50 years, with 40% to 52% of participants being male. The average duration of diabetes was reported in 3 studies and ranged from 5 to 9 years. Baseline A1C was reported in 6 studies, and 5 reported an average over 7%.
The 3 studies focused on improving foot selfcare behaviours 14, 15, 16 all used the Summary of The authors suggest that ongoing reminders are needed to support continued progress and achieve lasting behaviour changes. 14 Despite reporting significant findings, the overall number of days reported performing foot self-care activities remained well below the recommended guidelines in all 3 studies. The 3 studies measuring rates of health care provider foot exams or podiatrist visit 12, 17, 18 all showed significant improvements from baseline to follow-up (12 months). These exams were performed, or the referral made, by a pharmacist. One case study reported a point-of-care nerve conduction foot exam performed by a pharmacist in a community pharmacy. Poulose et al. 19 found that the majority (57%) of participants had mild or moderate conduction abnormalities. This contrasted with their same-day survey findings of symptoms of diabetic peripheral neuropathy (DPN), where only 13 (46%) participants reported no signs or symptoms of DPN. The NCStat DPN check nerve conduction test detected abnormalities in 8 (61%) of these 13 participants who reported no signs or symptoms of DPN.
Discussion
Pharmacists are an important provider of many aspects of diabetes care. They are highly accessible, are community based, do not usually require SYSTeMATiC ReView appointments and are often open after hours. They are ideally positioned to provide a wide range of services to all types of patients. 12 In this study, we have reported interventions including community pharmacists targeting both foot self-care activities, as well as foot examinations by health care providers. Both are extremely important in detecting early problems and prevention of foot disease progression. Our review reports 7 pharmacy-based and pharmacist-led interventions that resulted in improved foot care outcomes for adults with type 2 diabetes.
These 7 studies contribute to the best available evidence for pharmacy and pharmacist involvement in foot care for patients with diabetes. Various levels of pharmacist involvement were reported. Most studies were not randomized and were uncontrolled, with weak analyses; there are, however, some strengths of the individual findings and aspects to consider for future studies.
One study reported a direct pharmacist-led intervention in a community pharmacy setting, examining nerve conduction properties of patients with diabetes. 19 This was a simple SYSTeMATiC ReView point-of-care test that took 5 minutes to complete. Their results showed that nerve conduction abnormalities can be detected in people without signs or symptoms of peripheral neuropathy. These data may easily be incorporated into care plans and strategies to prevent longterm neuropathy and complications. It is additional information to supplement the regular assessment of patients with diabetes by pharmacists or other health care providers. Foot examinations are not a traditional pharmacist responsibility, nor are they typically reimbursed. Although these are well within pharmacists' scope of practice, it may not be feasible in each setting or case. As well, compensation models would need to be developed, perhaps incorporating advanced practice certifications, for example. First, raising awareness among pharmacists about foot problems and their role in prevention is necessary. From there, novel interventions may be developed to screen, refer or remind patients with diabetes about foot care practices.
Strengths and limitations
This is the first systematic review aimed at examining community pharmacy and pharmacist involvement in foot care for people with type 2 diabetes. The findings here will help inform future interventions in this setting, targeting the prevention of foot disease. This study is not without limitations. First, only studies published in English were considered. Second, only 1 reviewer conducted the preliminary screening of titles and abstracts. Third, the Downs and Black 13 quality assessment checklist did not assess the handling of missing data, and we did not consider them in our evaluation. Our final limitation is simply the variation in the studies included. This limited our interpretations and we were unable to pool any data. 
Clinical implications for the pharmacist

